Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk

Objective The human APOBEC3 family of proteins potently restricts HIV-1 replication APOBEC3B, one of the family genes, is frequently deleted in human populations. Two previous studies reached inconsistent conclusions regarding the effects of APOBEC3B loss on HIV-1 acquisition and pathogenesis. Therefore, it was necessary to verify the effects of APOBEC3B on HIV-1 infection in vivo. Methods Intact (I) and deletion (D) polymorphisms of APOBEC3B were analyzed using PCR. The syphilis, HBV and HCV infection rates, as well as CD4+ T cell counts and viral loads were compared among three APOBEC3B genotype groups (I/I, D/I, and D/D). HIV-1 replication kinetics was assayed in vitro using primary cells derived from PBMCs. Results A total of 248 HIV-1-infected Japanese men who have sex with men (MSM) patients and 207 uninfected Japanese MSM were enrolled in this study. The genotype analysis revealed no significant differences between the APOBEC3B genotype ratios of the infected and the uninfected cohorts (p = 0.66). In addition, HIV-1 disease progression parameters were not associated with the APOBEC3B genotype. Furthermore, the PBMCs from D/D and I/I subjects exhibited comparable HIV-1 susceptibility. Conclusion Our analysis of a population-based matched cohort suggests that the antiviral mechanism of APOBEC3B plays only a negligible role in eliminating HIV-1 in vivo.

[1]  Wei Zheng,et al.  APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. , 2013, Carcinogenesis.

[2]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[3]  Jason B. Nikas,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[4]  N. Kadowaki,et al.  APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells , 2012, Scientific Reports.

[5]  V. Pathak,et al.  APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4+ T Cells and Macrophages , 2012, Journal of Virology.

[6]  W. Sugiura,et al.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding , 2012, Nature Structural &Molecular Biology.

[7]  R. D’Aquila,et al.  APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo. , 2012, Virology.

[8]  V. Simon,et al.  APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1 , 2012, Journal of Virology.

[9]  Lela Lackey,et al.  Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1 , 2011, Journal of Virology.

[10]  V. Pathak,et al.  The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B , 2011, Journal of Virology.

[11]  V. Pathak,et al.  Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif , 2010, Journal of Virology.

[12]  W. Sugiura,et al.  Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. , 2010, Antiviral research.

[13]  T. Nakajima,et al.  No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations. , 2010, The Journal of infectious diseases.

[14]  Ariana Harari,et al.  Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes , 2010, Journal of Virology.

[15]  W. Brown,et al.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.

[16]  John S. Albin,et al.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics , 2010, Expert Reviews in Molecular Medicine.

[17]  Yusuke Nakamura,et al.  Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[18]  Y. Xiong,et al.  A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity , 2009, Journal of Virology.

[19]  M. Emerman,et al.  The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins , 2009, Journal of Virology.

[20]  J. Goedert,et al.  APOBEC3B deletion and risk of HIV-1 acquisition. , 2009, The Journal of infectious diseases.

[21]  M. Malim,et al.  Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets , 2009, Journal of Virology.

[22]  R. D’Aquila,et al.  Differences in APOBEC3G Expression in CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity , 2009, PLoS pathogens.

[23]  M. Malim,et al.  APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts , 2008, PLoS pathogens.

[24]  V. Pathak,et al.  Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif , 2008, Journal of Virology.

[25]  S. O’Brien,et al.  Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins , 2008, Journal of Virology.

[26]  J. Sankalé,et al.  Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. , 2008, The Journal of infectious diseases.

[27]  K. Strebel,et al.  HIV-1 Vif, APOBEC, and Intrinsic Immunity , 2008, Retrovirology.

[28]  B. Cullen,et al.  Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation. , 2008, RNA.

[29]  J. Greeve,et al.  Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro. , 2007, The Journal of general virology.

[30]  A. Gronenborn,et al.  Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G , 2007, Nucleic acids research.

[31]  E. Eichler,et al.  Population Stratification of a Common APOBEC Gene Deletion Polymorphism , 2007, PLoS genetics.

[32]  L. Lopalco,et al.  Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. , 2007, The Journal of infectious diseases.

[33]  P. Spearman,et al.  APOBEC3G Multimers Are Recruited to the Plasma Membrane for Packaging into Human Immunodeficiency Virus Type 1 Virus-Like Particles in an RNA-Dependent Process Requiring the NC Basic Linker , 2007, Journal of Virology.

[34]  M. Stenglein,et al.  APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism* , 2006, Journal of Biological Chemistry.

[35]  H. Takeuchi,et al.  Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect , 2006, Journal of Virology.

[36]  T. Rana,et al.  Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies , 2006, PLoS pathogens.

[37]  B. Cullen,et al.  Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. , 2005, Virology.

[38]  S. Wain-Hobson,et al.  Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. , 2005, The Journal of general virology.

[39]  S. Heath,et al.  Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. , 2005, The Journal of infectious diseases.

[40]  R. König,et al.  APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* , 2004, Journal of Biological Chemistry.

[41]  V. Pathak,et al.  Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs* , 2004, Journal of Biological Chemistry.

[42]  M. Malim,et al.  Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.

[43]  Yunkai Yu,et al.  Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.

[44]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[45]  Shuhua Xu,et al.  Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[46]  Xianghui Yu,et al.  Induction of APOBEC 3 G Ubiquitination and Degradation by an HIV-1 Vif-Cul 5-SCF Complex , 2022 .